Evidence map›Paper›PMID 31062319›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2019

Computational Analysis of Altering Cell Fate.

Hussein M Abdallah, Domitilla Del Vecchio

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hussein M AbdallahDepartment of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA, USA. hmabdall@mit.edu.
Domitilla Del VecchioDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.

Funding

Synthetic Genetic Controller Circuits to Reprogram Cell FateR01EB024591 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI COLLINS, JAMES J, DEL VECCHIO, DOMITILLA · 2017 to 2020
$2.5M
NIBIB NIH HHS R01 EB024591
6 · The paper itself

Abstract

The notion of reprogramming cell fate is a direct challenge to the traditional view in developmental biology that a cell's phenotypic identity is sealed after undergoing differentiation. Direct experimental evidence, beginning with the somatic cell nuclear transfer experiments of the twentieth century and culminating in the more recent breakthroughs in transdifferentiation and induced pluripotent stem cell (iPSC) reprogramming, have rewritten the rules for what is possible with cell fate transformation. Research is ongoing in the manipulation of cell fate for basic research in disease modeling, drug discovery, and clinical therapeutics. In many of these cell fate reprogramming experiments, there is often little known about the genetic and molecular changes accompanying the reprogramming process. However, gene regulatory networks (GRNs) can in some cases be implicated in the switching of phenotypes, providing a starting point for understanding the dynamic changes that accompany a given cell fate reprogramming process. In this chapter, we present a framework for computationally analyzing cell fate changes by mathematically modeling these GRNs. We provide a user guide with several tutorials of a set of techniques from dynamical systems theory that can be used to probe the intrinsic properties of GRNs as well as study their responses to external perturbations.

Indexed as

Cell DifferentiationCellular ReprogrammingGene Regulatory NetworksCell LineageComputational BiologyComputer SimulationHumansInduced Pluripotent Stem CellsModels, TheoreticalCell fateDynamical systemsGene regulatory networkiPSCTransdifferentiation

Identifiers

PMID31062319
PMCPMC7227774

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.